Continental Advisors’s Tenet Healthcare THC Stock Holding History

Continental Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,446	Closed	-$1.18M	–	63
2021 Q4	$1.18M	Sell	14,446 -5,124	-26%	-$374K	0.5%	52
2021 Q3	$1.3M	Sell	19,570 -16,671	-46%	-$1.18M	0.55%	52
2021 Q2	$2.43M	Sell	36,241 -35,821	-50%	-$2.22M	1.12%	33
2021 Q1	$3.75M	Sell	72,062 -25,300	-26%	-$1.28M	1.74%	20
2020 Q4	$3.89M	Hold	97,362	–	–	1.78%	16
2020 Q3	$2.39M	Buy	97,362 +15,000	+18%	+$383K	1.26%	27
2020 Q2	$1.49M	Buy	82,362 +5,000	+6%	+$98.5K	0.8%	50
2020 Q1	$1.11M	Buy	77,362 +29,692	+62%	+$852K	0.83%	51
2019 Q4	$1.81M	Sell	47,670 -18,839	-28%	-$564K	0.88%	42
2019 Q3	$1.47M	Hold	66,509	–	–	0.87%	49
2019 Q2	$1.37M	Buy	66,509 +8,000	+14%	+$184K	0.78%	51
2019 Q1	$1.69M	Sell	58,509 -51,001	-47%	-$1.26M	0.78%	50
2018 Q4	$1.88M	Hold	109,510	–	–	0.57%	66
2018 Q3	$3.12M	Sell	109,510 -13,000	-11%	-$429K	0.68%	52
2018 Q2	$4.11M	Sell	122,510 -118,814	-49%	-$3.69M	1.03%	41
2018 Q1	$5.85M	Buy	241,324 +3,000	+1%	+$59.7K	1.49%	25
2017 Q4	$3.61M	Buy	238,324 +75,500	+46%	+$1.06M	0.78%	46
2017 Q3	$2.67M	Sell	162,824 -30,000	-16%	-$509K	0.61%	57
2017 Q2	$3.73M	Buy	192,824 +80,854	+72%	+$1.41M	0.84%	41
2017 Q1	$1.98M	Sell	111,970 -16,000	-13%	-$297K	0.44%	68
2016 Q4	$1.9M	Buy	127,970 +6,900	+6%	+$124K	0.52%	66
2016 Q3	$2.74M	Buy	121,070 +16,000	+15%	+$416K	0.77%	46
2016 Q2	$2.9M	Sell	105,070 -12,600	-11%	-$372K	0.9%	39
2016 Q1	$3.4M	Buy	117,670 +38,000	+48%	+$989K	0.96%	33
2015 Q4	$2.41M	Buy	79,670 +48,800	+158%	+$1.6M	0.61%	54
2015 Q3	$1.14M	Sell	30,870 -630	-2%	-$32.6K	0.31%	97
2015 Q2	$1.82M	Sell	31,500 -4,500	-13%	-$230K	0.48%	69
2015 Q1	$1.78M	Buy	36,000 +28,500	+380%	+$1.33M	0.39%	81
2014 Q4	$380K	Hold	7,500	–	–	0.08%	137
2014 Q3	$445K	Sell	7,500 -7,000	-48%	-$391K	0.1%	132
2014 Q2	$681K	Buy	+14,500	New	+$655K	0.16%	105

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Continental Advisors's THC Position: Q1 2022 in Review

Continental Advisors sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 14,446 shares — an estimated $1.18M sold.

Continental Advisors first reported a position in THC in Q2 2014 and held it in 31 quarters. The position peaked at $5.85M in Q1 2018. 405 funds tracked by Wall St. Rank hold THC as of Q1 2022.

Continental Advisors reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
Continental Advisors sold 14,446 Tenet Healthcare shares in Q1 2022, an estimated $1.18M.
Continental Advisors first reported a position in Tenet Healthcare in Q2 2014 and held it in 31 quarters.
Continental Advisors's Tenet Healthcare position peaked at $5.85M in Q1 2018.
405 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Continental Advisors's 13F filing for Q1 2022, filed 16 May 2022.